Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · IEX Real-Time Price · USD
10.11
-0.37 (-3.53%)
Jul 22, 2024, 9:30 AM EDT - Market open
Kyverna Therapeutics Employees
Kyverna Therapeutics had 96 employees as of December 31, 2023.
Employees
96
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$790,792
Market Cap
431.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 96 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Health Catalyst | 1,300 |
| Pacific Biosciences of California | 796 |
| Nano-X Imaging | 164 |
| Absci | 155 |
| Nkarta | 150 |
| Korro Bio | 102 |
| Aura Biosciences | 89 |
| Ocugen | 65 |
KYTX News
- 2 days ago - The Schall Law Firm Welcomes Stakeholders Of Kyverna Therapeutics Inc To Join The KYTX Securities Fraud Probe - Accesswire
- 3 days ago - Kyverna Therapeutics Inc Investors Are Invited By The Schall Law Firm To Participate In The KYTX Securities Fraud Investigation - Accesswire
- 4 days ago - Investors Of Kyverna Therapeutics Inc Are Welcomed By The Schall Law Firm To Join The KYTX Securities Fraud Probe - Accesswire
- 5 days ago - Kyverna Therapeutics Inc Investors Are Invited By The Schall Law Firm To Participate In The Securities Fraud Investigation Into KYTX - Accesswire
- 6 days ago - Kyverna's KYV-101 Receives U.S. FDA RMAT Designation for KYV-101 in the Treatment of Patients With Refractory Stiff-Person Syndrome - PRNewsWire
- 6 days ago - The Schall Law Firm Invites Kyverna Therapeutics Inc Investors To Join The Securities Fraud Investigation Into KYTX - Accesswire
- 8 days ago - Investors Of Kyverna Therapeutics Inc Are Encouraged By The Schall Law Firm To Participate In The Securities Fraud Probe Into KYTX - Accesswire
- 9 days ago - Kyverna Therapeutics Inc Investors Are Invited By The Schall Law Firm To Join The Securities Fraud Investigation Into KYTX - Accesswire